The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy

5-Fluorouracil (5-FU)-based chemotherapy is the first-line treatment for colorectal cancer (CRC) but is hampered by chemoresistance. Despite its impact on patient survival, the mechanism underlying chemoresistance against 5-FU remains poorly understood. Here, we identified serine hydroxymethyltransf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogene
Autors principals: Chen, Jian, Na, Risi, Xiao, Chao, Wang, Xiao, Wang, Yupeng, Yan, Dongwang, Song, Guohe, Liu, Xueni, Chen, Jiayi, Lu, Huijun, Chen, Chunyan, Tang, Huamei, Zhuang, Guohong, Fan, Guangjian, Peng, Zhihai
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8195740/
https://ncbi.nlm.nih.gov/pubmed/33990700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-021-01815-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars